Sungyong You

7.3k total citations · 1 hit paper
151 papers, 4.0k citations indexed

About

Sungyong You is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sungyong You has authored 151 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 44 papers in Pulmonary and Respiratory Medicine and 30 papers in Cancer Research. Recurrent topics in Sungyong You's work include Prostate Cancer Treatment and Research (32 papers), Cancer, Lipids, and Metabolism (15 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Sungyong You is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Cancer, Lipids, and Metabolism (15 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Sungyong You collaborates with scholars based in United States, South Korea and China. Sungyong You's co-authors include Daehee Hwang, Sung‐Hoon Kim, Wan‐Uk Kim, Michael R. Freeman, Changyoun Kim, Seung‐Jae Lee, He-Jin Lee, Eliezer Masliah, Sarah Michael and Dong Hwan Ho and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Sungyong You

135 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

2013 650 citations Changyoun Kim, Sungyong You et al. Nature Communications profile →

Peers

Countries citing papers authored by Sungyong You

Since Specialization

Citations

This map shows the geographic impact of Sungyong You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sungyong You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sungyong You more than expected).

Fields of papers citing papers by Sungyong You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sungyong You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sungyong You. The network helps show where Sungyong You may publish in the future.

Co-authorship network of co-authors of Sungyong You

This figure shows the co-authorship network connecting the top 25 collaborators of Sungyong You. A scholar is included among the top collaborators of Sungyong You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sungyong You. Sungyong You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hierarchical chrysanthemum-shaped Co3S4@Ni3S4@C composites from bamboo-derived carbon with exceptional energy density for hybrid supercapacitors 2025 ·Journal of Energy Storage ·Tong Chen, Sungyong You, Zhihua Guo, Qianqian Zhang, (unknown), Nairong Chen, (unknown), Ning Yang, Mizi Fan, Weigang Zhao, Jiuping Rao	0
2	Investigating cytotoxic and inflammatory human IL-7 receptor low effector memory CD8+ T cells in lupus 2025 ·EBioMedicine ·(unknown), Min Sun Shin, Yong Sup Lee, Lais Osmani, (unknown), Helen Cai, (unknown), Jong Gyun Ahn, Hong‐Jai Park, Minhyung Kim, (unknown), Hyoungsu Kim, Man‐Hoon Han, (unknown), Sungyong You, Eun Bong Lee, Insoo Kang	0
3	CD105 blockade restores osimertinib sensitivity in drug-resistant EGFR-mutant non-small cell lung cancer 2025 ·Drug Resistance Updates ·(unknown), Sandrine Billet, Zhenqiu Liu, (unknown), Barliz Waissengrin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), K. Nathan Sankar, Edwin M. Posadas, Jean Lopategui, Sungyong You, Karen L. Reckamp, Neil A. Bhowmick	2
4	Epidemiology and Pathogenicity Analysis Based on Partial Recombinant PRRSV Strains in China 2025 ·Transboundary and Emerging Diseases ·Sungyong You, Lingguang Li, Junna Wang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
5	Microglial and neuronal fates following inhibition of CSF-1R in synucleinopathy mouse model 2024 ·Brain Behavior and Immunity ·Michiyo Iba, Yeon‐Joo Lee, (unknown), (unknown), Marcell Szabo, Robert A. Rissman, Sungyong You, Eliezer Masliah, Changyoun Kim	2
6	IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4+ T cell responses following COVID-19 mRNA vaccination 2024 ·EBioMedicine ·Hong‐Jai Park, Min Sun Shin, Junghee J. Shin, Hyoungsu Kim, (unknown), (unknown), (unknown), (unknown), Jason Catanzaro, Juan Young, Minhyung Kim, Sangjin Lee, Sangchoon Jeon, Sungyong You, Michael K. Racke, Richard Bucala, Insoo Kang	1
7	Complement C1q essential for aeroallergen sensitization via CSF1R+ conventional dendritic cells type 2 2023 ·Journal of Allergy and Clinical Immunology ·Hyung‐Geun Moon, Jacob D. Eccles, Seung-Jae Kim, Ki‐Hyun Kim, Youngmee Kim, Jalees Rehman, Hyun Lee, Pinal Kanabar, John W. Christman, Steven J. Ackerman, Christian Ascoli, Homan Kang, Hak Soo Choi, Minhyung Kim, Sungyong You, Gye Young Park	5
8	Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis 2022 ·Nature Communications ·Yiwu Yan, Bo Zhou, Qian Chen, (unknown), Mohini Kamra, (unknown), Yeon‐Joo Lee, Xiaopu Yuan, Leigh Ellis, Dolores Di Vizio, Edwin M. Posadas, Natasha Kyprianou, Beatrice S. Knudsen, Kavita Shah, Ramachandran Murali, Arkadiusz Gertych, Sungyong You, Michael R. Freeman, Wei Yang	28
9	Circulating tumor cells: A step toward precision medicine in hepatocellular carcinoma 2022 ·Journal of Gastroenterology and Hepatology ·Pai‐Chi Teng, Vatche G. Agopian, Ting‐Yi Lin, Sungyong You, Yazhen Zhu, Hsian‐Rong Tseng, Ju Dong Yang	9
10	Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity 2021 ·Clinical Cancer Research ·Yanping Wang, Sungyong You, Shengchen Su, Austin Yeon, (unknown), Sungjin Kim, James L. Mohler, Michael R. Freeman, Hyung L. Kim	26
11	Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer 2021 ·Molecular Therapy ·(unknown), (unknown), (unknown), Carrow I. Wells, Julie E. Pickett, (unknown), (unknown), (unknown), Lauren E. Howard, Sungyong You, Gayathri R. Devi, John DiGiovanni, Stephen J. Freedland, Jen‐Tsan Chi, David H. Drewry, Everardo Macias	23
12	Comprehensive palmitoyl‐proteomic analysis identifies distinct protein signatures for large and small cancer‐derived extracellular vesicles 2020 ·Journal of Extracellular Vesicles ·Javier Mariscal, Tatyana Vagner, Minhyung Kim, Bo Zhou, Andrew R. Chin, Mandana Zandian, Michael R. Freeman, Sungyong You, Andries Zijlstra, Wei Yang, Dolores Di Vizio	56
13	27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells 2020 ·Molecular Cancer Research ·Shweta Dambal, Mahmoud A. Alfaqih, (unknown), (unknown), Adela Ramírez‐Torres, (unknown), Mariana Reis-Sobreiro, Mirja Rotinen, (unknown), (unknown), Tijana Jovanović‐Talisman, Junhee Yoon, Sungyong You, James Turkson, Jen‐Tsan Chi, (unknown), Everardo Macias, Stephen J. Freedland	44
14	Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects 2020 ·International Neurourology Journal ·Muhammad Shahid, Minhyung Kim, Austin Yeon, (unknown), Woong‐Ki Kim, Sungyong You, Jayoung Kim	9
15	Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate 2019 ·Oncogene ·Yongfeng He, D. T. Johnson, Julie Yang, Huiqing Wu, Sungyong You, Junhee Yoon, Donghoon Lee, Won Kyung Kim, (unknown), Vien Le, Erika Hooker, Eun‐Jeong Yu, Joseph Geradts, Robert D. Cardiff, Zijie Sun	8
16	Emerin Deregulation Links Nuclear Shape Instability to Metastatic Potential 2018 ·Cancer Research ·Mariana Reis-Sobreiro, Jie‐Fu Chen, Tatiana Novitskaya, Sungyong You, Samantha Morley, Kenneth Steadman, Navjot Kaur Gill, (unknown), Mirja Rotinen, Chia-Yi Chu, Leland W.K. Chung, Hisashi Tanaka, Wei Yang, Beatrice S. Knudsen, Hsian‐Rong Tseng, Amy C. Rowat, Edwin M. Posadas, Andries Zijlstra, Dolores Di Vizio, (unknown)	53
17	Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer 2018 ·Cancers ·Nitya V. Sharma, Kathryn L. Pellegrini, Véronique Ouellet, Felipe Giuste, (unknown), Kenneth A. Watanabe, (unknown), (unknown), Sungyong You, (unknown), Paula M. Vertino, Karen N. Conneely, Adeboye O. Osunkoya, Dominique Trudel, Anne‐Marie Mes‐Masson, John A. Petros, Fred Saad, Carlos S. Moreno	28
18	MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer 2017 ·Cancer Research ·Valentina R. Minciacchi, Cristiana Spinelli, Mariana Reis-Sobreiro, Lorenzo Cavallini, Sungyong You, Mandana Zandian, Xiaohong Li, Rajeev Mishra, Paola Chiarugi, Rosalyn M. Adam, Edwin M. Posadas, Giuseppe Viglietto, Michael R. Freeman, Emanuele Cocucci, Neil A. Bhowmick, Dolores Di Vizio	120
19	Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome 2016 ·Cancer Research ·Sungyong You, Beatrice S. Knudsen, Nicholas Erho, Mohammed Alshalalfa, Mandeep Takhar, Hussam Al-Deen Ashab, Elai Davicioni, R. Jeffrey Karnes, Eric A. Klein, Robert B. Den, Ashley E. Ross, Edward M. Schaeffer, Isla P. Garraway, Jayoung Kim, Michael R. Freeman	132
20	RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization 2014 ·Endocrine Related Cancer ·Gina Chia‐Yi Chu, Haiyen E. Zhau, Ruoxiang Wang, André Rogatko, Feng Xu, Majd Zayzafoon, Youhua Liu, Mary C. Farach‐Carson, Sungyong You, Jayoung Kim, Michael R. Freeman, Leland W.K. Chung	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact